A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
TRESIBA (Insulin degludec) is a medication prescribed for people with diabetes mellitus. TRESIBA is an insulin product, which means it is an analog of regular human insulin.
In healthy people, insulin helps to regulate blood sugar to normal levels. Blood sugar that is too high or low can be harmful to the body. TRESIBA is a long-acting insulin that provides around-the-clock glycemic control.
Directions
TRESIBA (Insulin degludec) is a medication prescribed for people with diabetes mellitus. TRESIBA is an insulin product, which means it is an analog of regular human insulin.
In healthy people, insulin helps to regulate blood sugar to normal levels. Blood sugar that is too high or low can be harmful to the body. TRESIBA is a long-acting insulin that provides around-the-clock glycemic control.
Ingredients
The active ingredient in TRESIBA is insulin degludec.
Interactions
Some medications can change the blood sugar in people with diabetes. Speak with your doctor or pharmacist if you are taking any of the following:
Alcohol
Atypical Antipsychotics
Corticosteroids
Disopyramide
Diuretics
Estrogens/Progesterones
Fibrates
Fluoxetine
Isoniazid
Lithium
Monoamine Oxidase Inhibitors (MAOIs)
Niacin
Oral antidiabetic agents
Pentoxifylline
Phenothiazine derivatives
Pramlintide
Propoxyphene
Protease inhibitors
Salicylates
Somatostatin Analogues
Somatropin
Sulfonamide Antibiotics
Sympathomimetic agents
Thyroid replacement medication
The most common side effect of insulin therapy is low blood sugar (hypoglycemia). The following medications can mask the symptoms and make hypoglycemia harder to detect:
Beta-blockers
Clonidine
Guanethidine
Reserpine
Cautions
TRESIBA pens should never be shared between multiple patients.
The doctor should monitor potassium levels while using insulin therapy. They may also monitor kidney and liver function.
Tell your doctor if you have a history of cardiovascular disease.
Side Effects
The most common side effects of TRESIBA can include:
IMPORTANT NOTE:
The above information is intended to increase awareness of health information and does not suggest treatment or diagnosis. This information is not a substitute for individual medical attention and should not be construed to indicate that use of the drug is safe, appropriate, or effective for you. See your health care professional for medical advice and treatment.